Table 2. Univariate and multivariate analyses of odds ratio for an initial low sputum pH (<7.00).
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Characteristics | OR | 95% CI | P e | OR | 95% CI | P f |
| Age ≥61 yr | 8.750 | 2.100–36.251 | 0.004 | 24.535 | 2.685–224.213 | 0.005 |
| Male sex | 2.291 | 0.613–8.498 | 0.320 | |||
| Smoking history (current/ex-smoker vs. never) | 0.938 | 0.214–4.108 | 1.000 | |||
| Use of acid-suppressanta | 4.444 | 1.115–17.497 | 0.048 | |||
| Immunocompromisedb | 3.600 | 0.905–14.132 | 0.096 | |||
| Extensive lung lesionc | 1.697 | 0.466–6.165 | 0.514 | |||
| Presence of cavities | 0.300 | 0.080–1.130 | 0.105 | |||
| Sputum appearanced(M vs P) | 0.542 | 0.134–2.219 | 0.480 | 0.104 | 0.010–1.128 | 0.063 |
| Sputum bacterial load (<2+ vs ≥2+) | 3.208 | 0.877–11.719 | 0.111 | |||
Notes.
- CI
- confidence interval
- OR
- odds ratio
Acid-suppressant including histamine-2 receptor antagonist and proton pump inhibitor.
Immunocompromised; Patients having diabetes mellitus and/or corticosteroid user.
Extensive lung lesion; Radiological extent of parenchymal disease over one whole lung.
Sputum appearance classified by Miller and Jones’ classification.
Fisher’s exact test.
¶ Logistic regression.